Miromatrix Medical Inc. (MIRO)
3.39
0.02 (0.59%)
At close: Dec 12, 2023, 9:00 PM
0.59% (1D)
| Bid | n/a |
| Market Cap | 92.95M |
| Revenue (ttm) | 958.03K |
| Net Income (ttm) | -27.12M |
| EPS (ttm) | -1.14 |
| PE Ratio (ttm) | -2.973684210526316 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 631,561 |
| Avg. Volume (20D) | 163,022 |
| Open | 3.38 |
| Previous Close | 3.37 |
| Day's Range | 3.36 - 3.53 |
| 52-Week Range | 0.91 - 4.35 |
| Beta | 0.01 |
About MIRO
Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs. Its proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified human cells. The company has collaborations with The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart...
Industry Biotechnology
Sector Healthcare
IPO Date Jun 24, 2021
Employees 76
Stock Exchange NASDAQ
Ticker Symbol MIRO
Website https://www.miromatrix.com